NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 251 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,766 | -11.4% | 12,813 | -9.0% | 0.06% | -9.7% |
| Q2 2023 | $104,652 | +157.1% | 14,085 | +139.8% | 0.06% | +181.8% |
| Q1 2023 | $40,700 | -51.3% | 5,873 | -27.8% | 0.02% | -50.0% |
| Q4 2022 | $83,566 | +70.5% | 8,129 | +201.9% | 0.04% | +120.0% |
| Q3 2022 | $49,000 | -64.5% | 2,693 | +0.5% | 0.02% | -60.8% |
| Q2 2022 | $138,000 | +102.9% | 2,679 | +190.9% | 0.05% | +70.0% |
| Q1 2022 | $68,000 | -51.1% | 921 | -5.5% | 0.03% | -42.3% |
| Q4 2021 | $139,000 | -34.7% | 975 | -5.2% | 0.05% | -44.7% |
| Q3 2021 | $213,000 | -7.0% | 1,028 | -4.5% | 0.09% | 0.0% |
| Q2 2021 | $229,000 | -45.2% | 1,077 | -53.3% | 0.09% | -46.9% |
| Q1 2021 | $418,000 | +64.6% | 2,308 | +1.5% | 0.18% | +68.6% |
| Q4 2020 | $254,000 | -65.3% | 2,275 | -66.4% | 0.10% | -72.7% |
| Q3 2020 | $733,000 | +14.4% | 6,766 | -12.0% | 0.38% | +26.3% |
| Q2 2020 | $641,000 | – | 7,692 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |